Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 39282

1.

Once daily versus multiple daily mesalamine therapy for mild to moderate ulcerative colitis: a meta-analysis.

Li W, Zhang ZM, Jiang XL.

Colorectal Dis. 2016 May 23. doi: 10.1111/codi.13393. [Epub ahead of print] Review.

PMID:
27214762
2.

Prevalence and risk factors for venous thromboembolic complications in the Swiss Inflammatory Bowel Disease Cohort.

Alatri A, Schoepfer A, Fournier N, Engelberger RP, Safroneeva E, Vavricka S, Biedermann L, Calanca L, Mazzolai L; Swiss IBD Cohort Study Group.

Scand J Gastroenterol. 2016 May 20:1-6. [Epub ahead of print]

PMID:
27211077
3.

Targeting cytomegalovirus during ulcerative colitis flare-ups.

Nakase H, Onodera K.

Expert Rev Gastroenterol Hepatol. 2016 May 21. [Epub ahead of print]

PMID:
27211020
4.
5.

Clinical effects of a topically applied Toll-like receptor 9 agonist in active moderate-to-severe Ulcerative Colitis.

Atreya R, Bloom S, Scaldaferri F, Gerardi V, Admyre C, Karlsson Å, Knittel T, Kowalski J, Lukas M, Löfberg R, Nancey S, Petryka R, Rydzewska G, Schnabel R, Seidler U, Neurath M, Hawkey C.

J Crohns Colitis. 2016 May 20. pii: jjw103. [Epub ahead of print]

PMID:
27208386
6.

Vitamin D regulates the tight-junction protein expression in active ulcerative colitis.

Stio M, Retico L, Annese V, Bonanomi AG.

Scand J Gastroenterol. 2016 May 20:1-7. [Epub ahead of print]

PMID:
27207502
7.

[Fecal Calprotectin in Inflammatory Bowel Disease].

Lee J.

Korean J Gastroenterol. 2016 May 25;67(5):233-7. doi: 10.4166/kjg.2016.67.5.233. Review. Korean.

8.

Health-related Quality of Life in Patients with Inflammatory Bowel Disease 20 Years After Diagnosis: Results from the IBSEN Study.

Huppertz-Hauss G, Lie Høivik M, Jelsness-Jørgensen LP, Henriksen M, Høie O, Jahnsen J, Hoff G, Moum B, Bernklev T.

Inflamm Bowel Dis. 2016 May 19. [Epub ahead of print]

PMID:
27206016
9.

Endoscopic Mucosal Healing Predicts Favorable Clinical Outcomes in Inflammatory Bowel Disease: A Meta-analysis.

Reinink AR, Lee TC, Higgins PD.

Inflamm Bowel Dis. 2016 May 19. [Epub ahead of print]

PMID:
27206015
10.

Response of Iron Deficiency Anemia to Intravenous Iron Sucrose in Pediatric Inflammatory Bowel Disease.

Danko I.

J Pediatr Pharmacol Ther. 2016 Mar-Apr;21(2):162-8. doi: 10.5863/1551-6776-21.2.162.

11.

Fluoride: a risk factor for inflammatory bowel disease?

Follin-Arbelet B, Moum B.

Scand J Gastroenterol. 2016 May 19:1-6. [Epub ahead of print]

PMID:
27199224
12.

The influence of family pattern abnormalities in the early stages of life on the course of inflammatory bowel diseases.

Włodarczyk M, Sobolewska-Włodarczyk A, Stec-Michalska K, Fichna J, Wiśniewska-Jarosińska M.

Pharmacol Rep. 2016 Apr 30. pii: S1734-1140(16)30026-3. doi: 10.1016/j.pharep.2016.04.008. [Epub ahead of print] Review.

PMID:
27199029
13.

Efficacy of a "contact center-based communication" in optimizing the care of inflammatory bowel diseases.

Castiglione F, Imperatore N, Testa A, Rea M, Nardone OM, Gervetti P, Taranto ML, D'Onofrio G, Caporaso N, Rispo A.

Dig Liver Dis. 2016 Apr 11. pii: S1590-8658(16)30384-X. doi: 10.1016/j.dld.2016.03.028. [Epub ahead of print]

PMID:
27198737
14.

Abdominal pain: diagnostic issues in patient with coexisting Takayasu's arteritis and ulcerative colitis.

Kosałka J, Wawrzycka-Adamczyk K, Włudarczyk A, Machalica B, Sydor W.

Kardiol Pol. 2016;74(5):492. doi: 10.5603/KP.2016.0069. No abstract available.

PMID:
27197009
15.

Appendectomy does not decrease the risk of future colectomy in UC: results from a large cohort and meta-analysis.

Parian A, Limketkai B, Koh J, Brant SR, Bitton A, Cho JH, Duerr RH, McGovern DP, Proctor DD, Regueiro MD, Rioux JD, Schumm P, Taylor KD, Silverberg MS, Steinhart AH, Hernaez R, Lazarev M.

Gut. 2016 Apr 13. pii: gutjnl-2016-311550. doi: 10.1136/gutjnl-2016-311550. [Epub ahead of print]

PMID:
27196594
16.

Reduced risk of UC in families affected by appendicitis: a Danish national cohort study.

Nyboe Andersen N, Gørtz S, Frisch M, Jess T.

Gut. 2016 Apr 26. pii: gutjnl-2015-311131. doi: 10.1136/gutjnl-2015-311131. [Epub ahead of print]

PMID:
27196591
17.

The reduced chance of a live birth in women with IBD receiving assisted reproduction is due to a failure to achieve a clinical pregnancy.

Friedman S, Larsen PV, Fedder J, Nørgård BM.

Gut. 2016 Apr 21. pii: gutjnl-2016-311805. doi: 10.1136/gutjnl-2016-311805. [Epub ahead of print] No abstract available.

PMID:
27196568
18.

Cost-effectiveness of adalimumab, infliximab or vedolizumab as first-line biological therapy in moderate-to-severe ulcerative colitis.

Yokomizo L, Limketkai B, Park KT.

BMJ Open Gastroenterol. 2016 May 3;3(1):e000093. doi: 10.1136/bmjgast-2016-000093. eCollection 2016.

19.

Hyperbaric oxygen therapy stimulates colonic stem cells and induces mucosal healing in patients with refractory ulcerative colitis: a prospective case series.

Bekheit M, Baddour N, Katri K, Taher Y, El Tobgy K, Mousa E.

BMJ Open Gastroenterol. 2016 Apr 28;3(1):e000082. doi: 10.1136/bmjgast-2016-000082. eCollection 2016.

20.

IBD: in food we trust.

Marion-Letellier R, Savoye G, Ghosh S.

J Crohns Colitis. 2016 May 17. pii: jjw106. [Epub ahead of print] Review.

PMID:
27194533
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk